X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (307534) 307534
Publication (40781) 40781
Newspaper Article (7783) 7783
Newsletter (7288) 7288
Book Review (3085) 3085
Book Chapter (2325) 2325
Book / eBook (1035) 1035
Dissertation (669) 669
Conference Proceeding (576) 576
Government Document (199) 199
Web Resource (117) 117
Magazine Article (106) 106
Reference (102) 102
Trade Publication Article (58) 58
Data Set (43) 43
Streaming Video (27) 27
Transcript (12) 12
Paper (9) 9
Presentation (5) 5
Patent (3) 3
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (167860) 167860
animals (142025) 142025
index medicus (141514) 141514
proteins (70364) 70364
mice (63974) 63974
phosphorylation (62844) 62844
biochemistry & molecular biology (59323) 59323
cell biology (56750) 56750
signal transduction (56438) 56438
male (50445) 50445
oncology (50119) 50119
female (50106) 50106
research (41421) 41421
cancer (40690) 40690
kinases (40293) 40293
expression (39655) 39655
gene expression (32882) 32882
activation (32554) 32554
apoptosis (31200) 31200
rats (30237) 30237
mutation (28992) 28992
analysis (26141) 26141
cells, cultured (25678) 25678
cell line, tumor (24940) 24940
article (24514) 24514
research article (23939) 23939
physiological aspects (23408) 23408
genetic aspects (23379) 23379
cell line (22967) 22967
molecular sequence data (22440) 22440
multidisciplinary sciences (22136) 22136
tyrosine (21514) 21514
neurosciences (21506) 21506
cells (20671) 20671
immunology (20315) 20315
protein (20308) 20308
amino acid sequence (20177) 20177
middle aged (20052) 20052
adult (19000) 19000
protein-tyrosine kinases - metabolism (18862) 18862
medicine (18302) 18302
tumors (18121) 18121
protein binding (17557) 17557
biology (17486) 17486
health aspects (17158) 17158
tyrosine kinase (15952) 15952
signal transduction - drug effects (15916) 15916
aged (15767) 15767
genes (15642) 15642
gene-expression (15195) 15195
hematology (14909) 14909
rodents (14889) 14889
signal transduction - physiology (14240) 14240
receptor (14108) 14108
immunohistochemistry (14105) 14105
science (14102) 14102
cell proliferation (13932) 13932
genetics & heredity (13700) 13700
physiology (13638) 13638
pharmacology & pharmacy (13454) 13454
metastasis (13360) 13360
care and treatment (13324) 13324
protein kinases (13153) 13153
tyrosine phosphorylation (12831) 12831
blotting, western (12618) 12618
gene (12488) 12488
growth (12457) 12457
transfection (12294) 12294
life sciences (12171) 12171
in-vivo (12105) 12105
biochemistry (12062) 12062
identification (11896) 11896
medicine, research & experimental (11893) 11893
cell cycle (11889) 11889
enzyme inhibitors - pharmacology (11668) 11668
inhibition (11601) 11601
signal-transduction (11599) 11599
base sequence (11585) 11585
inflammation (11410) 11410
in-vitro (11371) 11371
angiogenesis (11358) 11358
enzyme activation (11217) 11217
ligands (11216) 11216
mice, inbred c57bl (11191) 11191
binding sites (11137) 11137
binding (10856) 10856
tumor cells, cultured (10704) 10704
studies (10703) 10703
endocrinology & metabolism (10547) 10547
breast cancer (10503) 10503
development and progression (10440) 10440
oxidative stress (10392) 10392
epidermal growth factor (10220) 10220
vascular endothelial growth factor (10072) 10072
protein-tyrosine kinase (10061) 10061
antineoplastic agents - pharmacology (10044) 10044
chemotherapy (10038) 10038
prognosis (9995) 9995
enzymes (9967) 9967
protein kinase inhibitors - pharmacology (9904) 9904
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (630) 630
Online Resources - Online (115) 115
UofT at Mississauga - Stacks (105) 105
Collection Dvlpm't (Acquisitions) - Vendor file (61) 61
UTL at Downsview - May be requested (50) 50
Collection Dvlpm't (Acquisitions) - Closed Orders (40) 40
UofT at Scarborough - Stacks (40) 40
Chemistry (A D Allen) - Stacks (37) 37
Engineering & Comp. Sci. - Stacks (23) 23
Earth Sciences (Noranda) - Stacks (18) 18
UofT at Scarborough - Withdrawn (9) 9
Trinity College (John W Graham) - Stacks (6) 6
St. Michael's College (John M. Kelly) - 2nd Floor (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Gerstein Science - Circulation Desk (4) 4
Royal Ontario Museum - Stacks (4) 4
UofT at Mississauga - Reference (3) 3
Chemistry (A D Allen) - Reference (2) 2
Gerstein Science - Missing (2) 2
Gerstein Science - Reference (2) 2
Media Commons - Microtexts (2) 2
Physics - Stacks (2) 2
UofT at Mississauga - Missing (2) 2
Victoria University E.J. Pratt - Oversize (2) 2
Baycrest Hospital - Stacks (1) 1
Chemistry (A D Allen) - May be requested in 6-10 wks (1) 1
Chemistry (A D Allen) - Theses (1) 1
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Earth Sciences (Noranda) - Circulation Desk (1) 1
Earth Sciences (Noranda) - Oversize (1) 1
Engineering & Comp. Sci. - Reference (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Reserve desk (1) 1
Gerstein Science - Theses (1) 1
Law (Bora Laskin) - Stacks (1) 1
Physics - Course Reserves (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Trinity College (John W Graham) - Oversize (1) 1
UofT at Mississauga - Circulation Desk (1) 1
UofT at Mississauga - Periodical Stacks (1) 1
Victoria University E.J. Pratt - Circulation Desk (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (323774) 323774
Japanese (2070) 2070
Chinese (1077) 1077
French (539) 539
German (380) 380
Russian (204) 204
Spanish (182) 182
Polish (79) 79
Korean (64) 64
Hungarian (59) 59
Czech (40) 40
Portuguese (38) 38
Italian (26) 26
Dutch (23) 23
Danish (12) 12
Swedish (12) 12
Finnish (11) 11
Ukrainian (11) 11
Norwegian (10) 10
Turkish (9) 9
Bulgarian (5) 5
Serbian (5) 5
Romanian (3) 3
Slovak (3) 3
Arabic (2) 2
Croatian (2) 2
Catalan (1) 1
Hebrew (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012, Methods in molecular biology, ISBN 1617793361, Volume 795., xi, 256
Book
Biochemical Journal, ISSN 0264-6021, 12/2007, Volume 408, Issue 3, pp. 297 - 315
The specificities of 65 compounds reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.... 
Drug discovery | Kinase profiling | Protein kinase | Anti-cancer drugs | Inhibitor specificity | RHO-ASSOCIATED KINASE | TUMOR PROGRESSION | FAMILY-MEMBERS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL-PROLIFERATION | protein kinase | P38 MAP KINASE | CYCLIN-DEPENDENT KINASES | RECEPTOR TYROSINE KINASES | drug discovery | kinase profiling | SB 203580 | anti-cancer drugs | ISOFORMS IN-VITRO | P90 RSK | inhibitor specificity | Amino Acid Sequence | Cell Line | Phosphorylation | Recombinant Proteins - antagonists & inhibitors | Animals | Mitogen-Activated Protein Kinases - antagonists & inhibitors | Humans | Drug Design | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | Mitogen-Activated Protein Kinases - metabolism | Spodoptera | Yes1, Yamaguchi sarcoma viral oncogene homologue 1 | CSK, C-terminal Src kinase | Lck, lymphocyte cell-specific protein-tyrosine kinase | EGF, epidermal growth factor | FGF-R, fibroblast-growth-factor receptor | PAK, p21-activated protein kinase | PDK, 3-phosphoinositide-dependent protein kinase | PI3K, phosphatidylinositol (phosphoinositide) 3-kinase | NEK, NIMA (never in mitosis in Aspergillus nidulans)-related kinase | RSK, p90 ribosomal S6 kinase | HEK-293 cells, human embryonic kidney-293 cells | VEGF, vascular endothelial growth factor (vasoendothelial growth factor) | EF2K, elongation-factor-2 kinase | CK, casein kinase | PTEN, phosphatase and tensin homologue deleted on chromosome 10 | ERK, extracellular-signal-regulated kinase | ATM, ataxia telangiectasia mutated | SRPK, serine-arginine protein kinase | IL-1, interleukin 1 | MNK, MAPK-integrating protein kinase | ROCK, Rho-dependent protein kinase | CaMKK, CaMK kinase | GST, glutathione transferase | MKK1, MAPK kinase-1 (also called MEK1, MAPK or ERK kinase 1) | GAK, cyclin G-associated kinase | FMK, fluoromethylketone | MST, mammalian homologue Ste20-like kinase | PKA, cAMP-dependent protein kinase | FKBP, FK506-binding protein | PPAR, peroxisome-proliferator-activated receptor | IKK, inhibitory κB kinase | PH, pleckstrin homology | MBP, myelin basic protein | AICAR, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside | MAPKAP-K, MAPK-activated protein kinase | Sf21, Spodoptera frugiperda (fall armyworm) 21 | MARK, microtubule-affinity-regulating kinase | PIM, provirus integration site for Moloney murine leukaemia virus | LPS, lipopolysaccharide | MSK, mitogen- and stress-activated protein kinase | MAPK, mitogen-activated protein kinase | MELK, maternal embryonic leucine-zipper kinase | His6, hexahistidine | CAK, cyclin-dependent kinase-activating kinase | Eph-A2, Ephrin A2 receptor | PLK, polo-like kinase | ATF2, activating transcription factor 2 | PKD, protein kinase D | Src, sarcoma kinase | AMPK, AMP-activated protein kinase | MMS, methyl methanesulfonate | CHK, checkpoint kinase | JNK, c-Jun N-terminal kinase | TORC1, mTOR (mammalian target of rapamycin)–raptor (regulatory associated protein of mTOR) complex | BRSK, brain-specific kinase | RIP2, receptor-interacting protein 2 | IGF-1, insulin-like growth factor-1 | S6K1, S6 kinase 1 | DYRK, dual-specificity tyrosine-phosphorylated and -regulated kinase | HIPK, homeodomain-interacting protein kinase | ZMP, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside monophosphate | PRAK, p38-regulated activated kinase | PKC, protein kinase C | Src-I1, Src inhibitor 1 | TANK, TRAF (tumour-necrosis-factor-receptor-associated factor)-family-member-associated nuclear factor κB activator | NFAT, nuclear factor for activated T-cells | PHK, phosphorylase kinase | GSK3, glycogen synthase kinase 3 | PKB, protein kinase B (also called Akt) | CaMK, calmodulin-dependent kinase | CDK, cyclin-dependent protein kinase | NDRG, N-myc downstream-regulated gene | SmMLCK, smooth-muscle myosin light-chain kinase | TBK1, TANK-binding kinase 1 | PRK, protein kinase C-related kinase | SGK, serum- and glucocorticoid-induced kinase
Journal Article
2010, 2nd ed., Methods in molecular biology, ISBN 9781607617945, Volume 661., xiv, 529
Book
Journal of Clinical Investigation, ISSN 0021-9738, 05/2009, Volume 119, Issue 5, pp. 1109 - 1123
Imatinib mesylate (IM), a potent inhibitor of the BCR/ABL tyrosine kinase, has become standard first-line therapy for patients with chronic myeloid leukemia... 
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, RESEARCH & EXPERIMENTAL | MALIGNANT GLIOMA-CELLS | BLAST CRISIS | CLINICAL RESISTANCE | BCR-ABL MUTATIONS | ENDOPLASMIC-RETICULUM | CYTOCHROME-C RELEASE | CASPASE ACTIVATION | IMATINIB RESISTANCE | CHRONIC MYELOID-LEUKEMIA | Transcription Factor CHOP - genetics | Neoplastic Stem Cells - cytology | Gene Expression - drug effects | Calcium - metabolism | Gene Expression - genetics | Microtubule-Associated Proteins - metabolism | Neoplastic Stem Cells - drug effects | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Endoplasmic Reticulum - metabolism | Antineoplastic Agents - therapeutic use | Autophagy - physiology | Thiazoles - therapeutic use | Autophagy - drug effects | Chloroquine - pharmacology | Neoplastic Stem Cells - metabolism | RNA Interference | Endoplasmic Reticulum - drug effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Macrolides - pharmacology | Antineoplastic Agents - pharmacology | Cell Death - drug effects | Dasatinib | Chloroquine - therapeutic use | Piperazines - therapeutic use | Pyrimidines - pharmacology | Imatinib Mesylate | Piperazines - pharmacology | Mice, Inbred C3H | Xenograft Model Antitumor Assays | Fusion Proteins, bcr-abl - genetics | Animals | Cell Death - physiology | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Fusion Proteins, bcr-abl - antagonists & inhibitors | Cell Line, Tumor | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Mice | Protein Kinase Inhibitors - pharmacology | Thiazoles - pharmacology | Benzamides | Macrolides - therapeutic use | Protein-Tyrosine Kinases - antagonists & inhibitors | Causes of | Physiological aspects | Genetic aspects | Chronic myeloid leukemia | Research | Drug therapy | Phagocytosis
Journal Article
Journal Article
Cold Spring Harbor Perspectives in Biology, ISSN 1943-0264, 2013, Volume 5, Issue 5, pp. a017459 - a017459
Journal Article
Journal Article
Cancer Science, ISSN 1347-9032, 12/2016, Volume 107, Issue 12, pp. 1800 - 1805
We proposed to compare the outcomes of first‐line epidermal growth factor receptor–tyrosine kinase inhibitor (EGFR‐TKI) alone with EGFR‐TKI plus whole‐brain... 
EGFR mutation | radiotherapy | prognosis | Brain metastasis | lung adenocarcinoma | CANCER PATIENTS | GEFITINIB | PHASE-II | RADIATION-THERAPY | TKI | ONCOLOGY | MUTATIONS | ERLOTINIB | Adenocarcinoma - pathology | Adenocarcinoma of Lung | Lung Neoplasms - mortality | Humans | Middle Aged | ErbB Receptors - genetics | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Brain Neoplasms - secondary | Adult | Female | Adenocarcinoma - genetics | Retrospective Studies | Brain Neoplasms - mortality | Lung Neoplasms - genetics | ErbB Receptors - antagonists & inhibitors | Proportional Hazards Models | Treatment Outcome | Combined Modality Therapy | Disease Progression | Protein Kinase Inhibitors - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Brain Neoplasms - therapy | Radiotherapy - methods | Aged | Mutation | Neoplasm Staging | Adenocarcinoma - mortality | Adenocarcinoma | Tyrosine | Brain | Medical research | Care and treatment | Epidermal growth factor | Lung cancer | Brain tumors | Medicine, Experimental | Phenols | Metastasis | Radiotherapy | Medical imaging | Epidermal growth factor receptors | Brain cancer | Oncology | Nervous system | Radiation therapy | Cancer therapies | Survival | Patients | Disease control | Metastases | Studies | Survival analysis | Neurotoxicity | Clonal deletion | Medical prognosis | Response rates | Protein-tyrosine kinase | Original
Journal Article